User login
December 2020
- Synthetic retinoid shows potential for myeloid malignancies
- Monthly azacitidine injections reduce relapse in acute myeloid leukemia and myelodysplastic syndrome
- Food supplements improve mitochondrial respiration in myelodysplastic syndrome
- Imetelstat curbs need for blood transfusions in myelodysplastic syndrome
- Azacitidine shows safety but lacks effectiveness for relapse reduction in myelodysplastic syndrome and acute myeloid leukemia
- Novel gene fusions surface more often in acute myeloid leukemia vs. myelodysplastic syndrome
- Genetic mutation burden can predict prognosis for myelodysplastic syndrome
November 2020
Dr. Guillermo Montalban Bravo: Specific guidelines for the management of SARS-CoV-2 infection in patients with MDS remains of paramount importance
- COVID-19 may be more lethal in MDS patients
- New form of programmed cell death has cancer treatment implications
- Genome study identifies potential treatment target for myelodysplastic syndrome patients
- Dialysis predicts increased risk of myelodysplastic syndrome
- Bronchoscopy remains a safe choice for most patients with malignant hematologic disorders
- Most transfusion-dependent MDS patients report positive quality of life
- Luspatercept shows promise as efficacy marker in MDS patients
- Gene mutations may predict risk of vascular events in MDS